Inventor
HOYER DENTON W
US16 patents
⚠️ This page may combine multiple inventors who share the name “HOYER DENTON W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MYDECINE INNOVATIONS GROUP INC
6 patentsUS12064415B2Aug 20, 2024
Psilocin prodrug compounds and methods of synthesizing the same
MYDECINE INNOVATIONS GROUP INC0 citations59
US11952342B2Apr 9, 2024
Aza-substituted psilocin analogs and methods of synthesizing the same
MYDECINE INNOVATIONS GROUP INC0 citations59
US11939292B1Mar 26, 2024
Aza-substituted psilocin analogs and methods of synthesizing the same
MYDECINE INNOVATIONS GROUP INC0 citations59
US12569466B2Mar 10, 2026
Short-acting psychoactive compounds of the MDMA class
MYDECINE INNOVATIONS GROUP INC0 citations58
US12570621B2Mar 10, 2026
Short-acting 3,4-methylenedioxymethamphetamine (MDMA) analogs incorporating benzothiazole
MYDECINE INNOVATIONS GROUP INC0 citations58
US11896577B2Feb 13, 2024
Short-acting psychoactive compounds of the MDMA class
MYDECINE INNOVATIONS GROUP INC1 citations58
VERTEX PHARMA
5 patentsUS6121266ASep 19, 2000
Pyridazines as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA21 citations92
US6576614B1Jun 10, 2003
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA7 citations73
US5985838ANov 16, 1999
Peptide analogs as irreversible interleukin-1β protease inhibitors
VERTEX PHARMA8 citations73
US6995261B2Feb 7, 2006
4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA1 citations62
US6624166B1Sep 23, 2003
Pyridazines as interleukin-1β converting enzyme inhibitors
VERTEX PHARMA1 citations62